Clinical trial · Observational
Observational Study of Survival Outcomes of Stage IV Cancer Patients
Observational Study of Survival Times of Stage IV Cancer Patients
NCT01843985CI-TRIAL-00010181unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Patients diagnosed with Stage IV cancer (solid tumors only) are evaluated to determine whether they are candidates for traditional chemotherapy. If eligible, patients are offered traditional chemotherapy, low-dose chemotherapy, or palliative care. If ineligible, patients are offered low-dose chemotherapy or palliative care. Patients will be monitored for 5 years and survival data recorded.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Stage IV Cancer (Solid Tumors Only) | Malignant Neoplasm | CURATED_BROADER | 0.78 |
| Survival | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (5)
- label
- 1. Eligible RCT/Elect RCT
- description
- Eligible for regular chemotherapy, elects and receives regular chemotherapy
- label
- 2. Eligible RCT/Elect LDC
- description
- Eligible for regular chemotherapy, elects and receives low-dose chemotherapy
- label
- 3. Eligible RCT/Elect PCO
- description
- Eligible for regular chemotherapy, elects and receives palliative care only
- label
- 4. Ineligible RCT/Elect LDC
- description
- Ineligible for regular chemotherapy, elects and receives low-dose chemotherapy
- label
- 5. Ineligible RCT/Elect PCO
- description
- Ineligible for regular chemotherapy, elects and receives palliative care only
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Presenting with Stage IV cancer (solid tumors only) Exclusion Criteria: * Patient declines inclusion
References
Publications (0)
Data not yet available
No reference posted for this study.